Relapsed focal segmental glomerulosclerosis and severe acute kidney injury after Oxford-AstraZeneca (AZ) COVID-19 vaccine

Arch Med Sci. 2022 Nov 7;18(6):1693-1695. doi: 10.5114/aoms/153477. eCollection 2022.
No abstract available